Jay T. Backstrom

Dr. Backstrom joins the Disc Medicine Board with over 30 years of experience in research and development. He recently served as Executive Vice President, Head of Research and Development at Acceleron and was previously Chief Medical Officer (and Head of Regulatory Affairs) at Celgene, which he joined in 2008 as Vice President of Clinical Research and Development, with a focus in hematology and oncology. Prior to Celgene, he served as Vice President of Global Medical Affairs and Safety at Pharmion. Dr. Backstrom began his career at Marion Merrell Dow and continued as part of its successor companies including Hoechst Marion Roussel. Prior to his professional career in the biotech industry, Dr. Backstrom served as Staff Physician and Medical Director of the Samuel U. Rodgers Community Health Center in Kansas City, Missouri. Dr. Backstrom holds an M.D. from Temple University School of Medicine and received post-graduate training in Internal Medicine at Temple University Hospital. He also earned a Master’s in Public Health from Saint Louis University School of Public Health.